Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Karen L, Ericson"'
Autor:
Michael P, Whyte, Fan, Zhang, Deborah, Wenkert, Karen E, Mack, Vinieth N, Bijanki, Karen L, Ericson, Stephen P, Coburn
Publikováno v:
Bone. 154
Hypophosphatasia (HPP) is the heritable dento-osseous disease caused by loss-of-function mutation(s) of the gene ALPL that encodes the tissue-nonspecific isoenzyme of alkaline phosphatase (TNSALP). TNSALP is a cell-surface homodimeric phosphomonoeste
Autor:
Michael P, Whyte, Jennifer D, May, William H, McAlister, Katherine, Burgener, Samuel R, Cortez, Raymond, Kreienkamp, Olivia, Castro, Rachel, Verzola, Ana Solis, Zavala, Christopher C, McPherson, Gary S, Gottesman, Karen L, Ericson, Stephen P, Coburn, Ana Maria, Arbelaez
Publikováno v:
Bone. 150
Pyridoxal 5'-phosphate (PLP), the principal circulating form of vitamin B
Autor:
Per Magnusson, Nina S. Ma, Gary S. Gottesman, William H. McAlister, Karen L. Ericson, Angela Nenninger, Steven Mumm, Michael P. Whyte, Vinieth N. Bijanki
Publikováno v:
Bone. 138
Alkaline phosphatase (ALP) in humans comprises a family of four cell-surface phosphomonoester phosphohydrolase isozymes. Three genes separately encode the "tissue-specific" ALPs whereas the fourth gene encodes ubiquitous homodimeric "tissue-nonspecif
Publikováno v:
Bone. 110:96-106
Hypophosphatasia (HPP) is the inborn-error-of-metabolism due to loss-of-function mutation(s) of the ALPL (TNSALP) gene that encodes the tissue non-specific isoenzyme of alkaline phosphatase (TNSALP). TNSALP represents a family of cell-surface phospho
Autor:
Stephen P. Coburn, Fan Zhang, Karen L. Ericson, Deborah Wenkert, Karen E. Mack, Michael P. Whyte, Vinieth N. Bijanki
Publikováno v:
Bone. 154:116204
Hypophosphatasia (HPP) is the heritable dento-osseous disease caused by loss-of-function mutation(s) of the gene ALPL that encodes the tissue-nonspecific isoenzyme of alkaline phosphatase (TNSALP). TNSALP is a cell-surface homodimeric phosphomonoeste
Autor:
Michael P. Whyte, Samuel R. Cortez, Katherine Burgener, Raymond Kreienkamp, William H. McAlister, Stephen P. Coburn, Ana Solis Zavala, Olivia Castro, Gary S. Gottesman, Karen L. Ericson, Rachel Verzola, Jennifer D. May, Ana Maria Arbelaez, Christopher McPherson
Publikováno v:
Bone. 150:116007
Pyridoxal 5′-phosphate (PLP), the principal circulating form of vitamin B6 (B6), is elevated in the plasma of individuals with hypophosphatasia (HPP). HPP is the inborn-error-of-metabolism caused by loss-of-function mutation(s) of ALPL, the gene th
Autor:
Scott M. Smith, Robert Ploutz-Snyder, Karen L. Ericson, Martina Heer, Sara R. Zwart, C. Robert Gibson, Thomas H. Mader
Publikováno v:
The Journal of Nutrition. 142:427-431
Approximately 20% (7 of 38) of astronauts on International Space Station (ISS) missions have developed measurable ophthalmic changes after flight. This study was conducted to determine if the folate- and vitamin B-12-dependent 1-carbon metabolic path
Autor:
Priscilla G. Masse, Marcel Caissie, Maisha B. Pacifique, Edgard Delvin, Barham H Arjmandi, Carole C. Tranchant, Karen L Ericson, Sharon M. Donovan
Publikováno v:
Journal of the American College of Nutrition. 29:419-429
This investigation on a homogenous cohort of young adult Caucasian type 1 diabetic (IDDM) patients (1) aimed at studying the occurrence of low bone mineral density (BMD) at an early stage prior to menopause (i.e., during the first decade after peak b
Autor:
Scott M. Smith, PL Gillman, Shanna Rodgers, Sara R. Zwart, Ann Rogers, Megan Wolf, Kristen Hitchcox, Karen L. Ericson
Publikováno v:
Clinical Biochemistry. 42:907-910
Objectives We investigated the stability of 36 analytes related to clinical chemistry in a controlled storage study. Design and methods Blood was collected from 11 subjects and was maintained for 45 min, 2.5 h, 5 h, or 24 h after phlebotomy before ce
Autor:
John C. Carey, Stephen P. Coburn, Steven Mumm, Michael P. Whyte, David A. Stevenson, Janice L. B. Byrne, Karen L. Ericson
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 93:3443-3448
Context: Hypophosphatasia (HPP) is a heritable metabolic disorder of the skeleton that includes variable expressivity conditioned by gene dosage effect and the variety of mutations in the tissue nonspecific alkaline phosphatase (TNSALP) gene. Patient